Next, we tested the effect of end resection factors by targeting critical molecules of HR and Fanconi anemia (FA) pathways such as BRCA1, BRCA2, USP1, FANCF, FANCI, FANCA, FANCD2, FANCE, FANCL, and FANCM. The gene discussed is FANCE; the disease is Friedreich ataxia.